|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis显示文摘 | Curtis K. Argo Patrick G. Northup Abdullah M.S. Al-Osaimi Stephen H. Caldwell | 2009 | Journal of Hepatology2009，，2： | 3 |
| 2 | Spontaneous bacterial peritonitis prevalence in pretransplant patients and its effect on survival and graft loss post-transplant显示文摘AIM To investigate the incidence of spontaneous bacterial peritonitis(SBP) in pre-transplant patients and its effect on post transplant mortality and graft failure. METHODS We conducted a retrospective cohort study of patient records from the organ procurement and transplant network data set. Patients were identified by the presence of SBP pre-transplant. Univariate post-transplant survival models were constructed using the Kaplan-Meier technique and multivariate models were constructed using the Cox proportional hazards model. Variables that affected post-transplant graft survival were identified in the SBP population. RESULTS Forty-seven thousand eight hundred and eighty patient records were included in the analysis for both groups, and 1966(4.11%) patients were identified in the data set as having pre-transplant SBP. Patients that had pre-transplant SBP had higher rates of graft loss from recurrent hepatitis C virus(HCV)(3.6% vs 2.0%, P < 0.0001), infections leading to graft loss(1.9% vs 1.3%, P = 0.02), primary non-function(4.3% vs 3.0%, P < 0.0001) and chronic rejection(1.1% vs 0.7%, P = 0.04). Kaplan-Meier survival analysis showed a statistically significant difference in all-cause survival in patients with a history of SBP vs those without(P < 0.0001). Pretransplant history of SBP was independently predictiveof mortality due to recurrent HCV(HR = 1.11, 95%CI: 1.02-1.21, P < 0.017) after liver transplantation.CONCLUSION HCV patients prior to the advent of directing acting anti-viral agents had a higher incidence of pre-transplant SBP than other patients on the liver transplant wait list. SBP history pre-transplant resulted in a higher rate of graft loss due to recurrent HCV infection and chronic rejection. | Neeral L Shah Nicolas M Intagliata Zachary H Henry Curtis K Argo Patrick G Northup | 2016 | World Journal of Hepatology2016，8，36： | 2 |
| 3 | Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis显示文摘AIM To examine if liver transplant recipients with high-risk non-alcoholic steatohepatitis(NASH) are at increased risk for pre-transplant portal venous thrombosis.METHODS Data on all liver transplants in the United States from February 2002 through September 2014 were analyzed. Recipients were sorted into three distinct groups: High-risk(age > 60, body mass index > 30 kg/m2, hypertension and diabetes), low-risk and non-NASH cirrhosis. Multivariable logistic regression models were constructed.RESULTS Thirty-five thousand and seventy-two candidates underwent liver transplantation and of those organ recipients, 465 were transplanted for high-risk and 2775 for lowrisk NASH. Two thousand six hundred and twentysix(7.5%) recipients had pre-transplant portal vein thrombosis; 66(14.2%) of the high-risk NASH group had portal vein thrombosis vs 328(11.8%) of the lowrisk NASH group. In general, all NASH recipients were less likely to be male or African American and more likely to be obese. In adjusted multivariable regression analyses, high-risk recipients had the greatest risk ofpre-transplant portal vein thrombosis with OR = 2.11(95%CI: 1.60-2.76, P < 0.001) when referenced to the non-NASH group.CONCLUSION Liver transplant candidates with high-risk NASH are at the greatest risk for portal vein thrombosis development prior to transplantation. These candidates may benefit from interventions to decrease their likelihood of clot formation and resultant downstream hepatic decompensating events. Prospective study is needed. | Jonathan G Stine Curtis K Argo Shawn J Pelletier Daniel G Maluf Stephen H Caldwell Patrick G Northup | 2017 | World Journal of Hepatology2017，9，3： | 2 |
| 4 | Epidemiology and Natural History of Non-Alcoholic Steatohepatitis显示文摘 | Curtis K. Argo Stephen H. Caldwell | 2009 | Clinics in Liver Disease2009，，4： | 2 |
| 5 | Thermalstability and protein structure显示文摘 | Argos P Rossman M G Grau U M | 1979 | Biochemistry1979，18，： | 1 |
| 6 | Knowledge-based protein secondary structure assignment显示文摘 | FRISHMAN D ARGOS P | 1995 | Proteins:Structure Function and Genetics1995，23，4： | 1 |
| 7 | Protein- protein crystalpacking contacts 显示文摘 | Carugo O Argos P | 1997 | Protein Sci1997，，6： | 1 |
| 8 | Palipefidone extended- release tablets for the acute and maintenance treatment of schizophrenia 显示文摘 | Fowler JA Bettinger TL Argo TR | 2008 | Clin Ther2008，30，2： | 1 |
| 9 | Meta-analyses of the effectiveness of warning labels显示文摘 | JENNIFER J ARGO KELLEY J MAIN | 2004 | Journal of Public Policy & Marketing2004，23，2： | 1 |
| 10 | Paliperidone extended release tablets for the acute and maintenance treatment of schizophrenia 显示文摘 | Fowler J A Bettinger T L Argo T R | 2008 | ClinTher2008，30，2： | 1 |
| 11 | Successful embryo transfer following artificial insemination of supcrovulatcd fallow deer (Dama dama)显示文摘 | Jabbour HN Marshall VS Argo CMcG Hooton Jct al | 1994 | Rcprod Fcrtil Dcv1994，6，： | 1 |
| 12 | Laparoscopic versus open insertion of the peritoneal catheter in ventriculoperi- toneal shunt placement: review of 810 consecutive cases 显示文摘 | Naiel RP Argo JL Shannon CN | 2011 | J Neurosurg2011，115，1： | 1 |
| 13 | Operative treatment of ulnar collateral ligament insufficiency of the elbow in female athletes显示文摘 | Argo D Trenhaile SW Savoie FH 3rd | 2006 | Am J Sports Med2006，34，3： | 1 |
| 14 | Molecular and proteomic an- alyses highlight the importance of ubiquitination for the stress re- sistance, metabolic adaptation, morphogenetic regulation and vir- ulence of Candida albicans 显示文摘 | Leach MD Stead DA Argo E | 2011 | Mol Microbiol2011，79，6： | 1 |
| 15 | Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses显示文摘 | Kamer G Argos P | 1984 | Nucleic Acids Res1984，12，18： | 1 |
| 16 | Porosity in modified aluminum alloy castings 显示文摘 | Gruzleski J E | 1988 | AFS Trans1988，96，： | 1 |
| 17 | Epidemiology and natural history of non-alcoholic steatohepatitis 显示文摘 | Argo C K Caldwell S H | 2009 | Clin Liver Dis2009，13，4： | 1 |
| 18 | Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia显示文摘 | FOWLER JA BETTINGER TL ARGO TR | 2008 | Clin Ther2008，30，2： | 1 |
| 19 | Primary structural comparison of RNA-dependent polymerases from plant,animal and bacterial viruses显示文摘 | KAMER G ARGOS P | 1984 | Nucleic Acids Res1984，12，7： | 1 |
| 20 | Therapy of NAFLD:insulin sensitizing agents显示文摘 | CALDWELL SH ARGO CK AL-OSAIMI AM | 2006 | J Clin Gastroenterol2006，40，31： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员